On June 15, Eton Pharmaceuticals Inc Entered Into Amendment To Asset Purchase Deal Dated December 31, 2020 By, Between Co And Azurity; Will Sell Back To Azurity Royalty Interests It Received Under Original Agreement For Total Consideration Of $5.5M
Benzinga Newsdesk - Jun 15, 2023, 4:25PM